Academic Journal

Machine Model-Specific Delivery Sequence Optimization for Spot-scanning Proton Arc Therapy Using a Compact Superconducting Synchrocyclotron.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Machine Model-Specific Delivery Sequence Optimization for Spot-scanning Proton Arc Therapy Using a Compact Superconducting Synchrocyclotron.
Συγγραφείς: Liu P; Department of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.; Department of Medical Physics, School of Medicine, Wayne State University, Detroit, Michigan, USA., Zhao L; Department of Radiation Oncology, Medstar Georgetown University Hospital, Washington, District of Columbia, USA., Cong X; Department of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA., Liu G; Department of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA., Li X; Department of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA., Ding X; Department of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
Πηγή: Medical physics [Med Phys] 2026 Sep; Vol. 53 (9), pp. e70658.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: John Wiley and Sons, Inc Country of Publication: United States NLM ID: 0425746 Publication Model: Print Cited Medium: Internet ISSN: 2473-4209 (Electronic) Linking ISSN: 00942405 NLM ISO Abbreviation: Med Phys Subsets: MEDLINE
Imprint Name(s): Publication: 2017- : Hoboken, NJ : John Wiley and Sons, Inc.
Original Publication: Lancaster, Pa., Published for the American Assn. of Physicists in Medicine by the American Institute of Physics.
Ιατρικοί όροι (MeSH): Proton Therapy*/instrumentation , Proton Therapy*/methods, Radiotherapy Planning, Computer-Assisted/methods ; Brain Neoplasms/radiotherapy ; Radiotherapy Dosage ; Humans
Περίληψη: Background: Spot scanning proton arc therapy (SPArc) combines the dosimetric advantages of proton therapy with the beam-angle freedom of arc delivery. However, current planning algorithms rely on static delivery assumptions that do not account for the temporal characteristics of pulsed-beam synchrocyclotron systems during continuous gantry rotation. This mismatch between nominal plans and actual treatment delivery may lead to clinically meaningful dose deviations.
Purpose: To develop and evaluate a dynamic arc delivery sequencing optimization framework that incorporates machine-specific delivery characteristics to minimize deviations between planned and delivered dose in SPArc.
Methods: A five-step dynamic arc delivery sequencing optimization framework was developed. The framework includes: (1) static and dynamic delivery time calculation, (2) spot and energy-layer disassembling, (3) incorporation of dynamic delivery timing into control points, (4) spot-weight fine-tuning, and (5) reconstruction of energy-layer sequences. Five multi-metastatic brain stereotactic radiosurgery cases were retrospectively evaluated. Delivery accuracy, efficiency and plan quality were assessed using virtual machine logfiles.
Results: The sequencing optimization framework substantially improved delivery accuracy while preserving plan quality and efficiency. For the total gross tumor volume, the mean absolute D98 deviation between planned and virtual logfile reconstructed doses decreased from 77.4 ± 81.0 cGyE (4.2 ± 4.5%) with static SPArc plans to 9.6 ± 4.0 cGyE (0.5 ± 0.2%) after sequencing optimization. For the worst metastasis in each case, D98 deviation decreased from 184.4 ± 145.2 cGyE (9.8 ± 7.9%) to 19.0 ± 16.4 cGyE (1.0 ± 0.8%), and D2 deviation decreased from 148.4 ± 114.4 cGyE (6.8 ± 5.6%) to 13.2 ± 8.6 cGyE (0.6 ± 0.4%). Target coverage and normal brain sparing remained statistically unchanged (p > 0.05), and total delivery times differed by < 1 s.
Conclusions: The proposed sequencing optimization framework addresses the temporal mismatch between static SPArc planning and dynamic delivery in synchrocyclotron-based systems. By improving delivery accuracy without compromising plan quality or delivery efficiency, the framework demonstrates the feasibility of incorporating machine-specific delivery timing into dynamic proton arc therapy.
(© 2026 American Association of Physicists in Medicine.)
References: Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):624-30. (PMID: 20117294)
Med Phys. 2023 Mar;50(3):1305-1317. (PMID: 36373893)
J Appl Clin Med Phys. 2012 Mar 08;13(2):3725. (PMID: 22402389)
Front Oncol. 2022 Nov 10;12:1036139. (PMID: 36439480)
Radiat Oncol. 2020 Jan 30;15(1):21. (PMID: 32000817)
Lancet. 2026 Jan 10;407(10524):174-184. (PMID: 41391462)
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1107-1116. (PMID: 27869083)
J Appl Clin Med Phys. 2024 Sep;25(9):e14486. (PMID: 39137008)
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):871-3. (PMID: 24267966)
Radiat Oncol. 2022 May 7;17(1):87. (PMID: 35525993)
Front Oncol. 2022 May 19;12:804036. (PMID: 35664795)
JAMA Oncol. 2020 Feb 1;6(2):237-246. (PMID: 31876914)
Comput Biol Med. 2022 Sep;148:105609. (PMID: 35803749)
Semin Radiat Oncol. 2013 Apr;23(2):77-87. (PMID: 23473684)
Phys Med. 2024 Oct;126:104816. (PMID: 39326286)
Acta Oncol. 2023 Jan;62(1):48-52. (PMID: 36729848)
Phys Med Biol. 2012 Jun 7;57(11):R99-117. (PMID: 22571913)
Med Dosim. 2024 Spring;49(1):2-12. (PMID: 37996354)
Med Phys. 2026 Sep;53(9):e70658. (PMID: 42670024)
Acta Oncol. 2020 Oct;59(10):1178-1185. (PMID: 32421375)
J Appl Clin Med Phys. 2025 Apr;26(4):e14611. (PMID: 39704661)
Med Phys. 2026 Jan;53(1):e70213. (PMID: 41455058)
Med Phys. 2024 Apr;51(4):3067-3075. (PMID: 38064634)
Grant Information: R01 CA301448 United States CA NCI NIH HHS; R01CA301448 United States CA NCI NIH HHS
Contributed Indexing: Keywords: delivery accuracy; proton arc therapy; synchrocyclotron
Entry Date(s): Date Created: 20260831 Date Completed: 20260831 Latest Revision: 20260926
Update Code: 20260926
PubMed Central ID: PMC13527260
DOI: 10.1002/mp.70658
PMID: 42670024
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:2473-4209
DOI:10.1002/mp.70658